Boiron 将来の成長

Future 基準チェック /36

Boiron is forecast to grow earnings and revenue by 26.2% and 3.6% per annum respectively. EPS is expected to grow by 26.9% per annum. Return on equity is forecast to be 13.1% in 3 years.

主要情報

26.2%

収益成長率

26.9%

EPS成長率

Pharmaceuticals 収益成長	23.7%
収益成長率	3.6%
将来の株主資本利益率	13.1%
アナリストカバレッジ	Low
最終更新日	07 Oct 2024

今後の成長に関する最新情報

更新なし

Recent updates

業績と収益の成長予測

OTCPK:BOIR.F - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	528	40	55	81	1
12/31/2025	511	30	44	69	1
12/31/2024	493	20	56	58	1
6/30/2024	482	24	25	43	N/A
3/31/2024	487	30	26	44	N/A
12/31/2023	493	36	27	45	N/A
9/30/2023	505	42	23	40	N/A
6/30/2023	517	48	18	34	N/A
3/31/2023	526	46	29	46	N/A
12/31/2022	534	45	40	59	N/A
9/30/2022	528	48	44	64	N/A
6/30/2022	522	51	48	69	N/A
3/31/2022	489	40	31	51	N/A
12/31/2021	455	29	13	33	N/A
9/30/2021	453	23	13	34	N/A
6/30/2021	450	18	14	34	N/A
3/31/2021	482	22	31	51	N/A
12/31/2020	514	26	48	68	N/A
9/30/2020	534	33	52	76	N/A
6/30/2020	554	40	57	84	N/A
3/31/2020	556	40	35	67	N/A
12/31/2019	557	41	13	51	N/A
9/30/2019	569	38	19	59	N/A
6/30/2019	580	35	25	68	N/A
3/31/2019	592	46	31	76	N/A
12/31/2018	604	57	37	84	N/A
9/30/2018	609	66	43	92	N/A
6/30/2018	613	75	49	99	N/A
3/31/2018	615	77	N/A	102	N/A
12/31/2017	618	78	N/A	105	N/A
9/30/2017	616	77	N/A	104	N/A
6/30/2017	615	76	N/A	103	N/A
3/31/2017	615	77	N/A	106	N/A
12/31/2016	614	78	N/A	110	N/A
9/30/2016	616	78	N/A	103	N/A
6/30/2016	617	79	N/A	95	N/A
3/31/2016	612	76	N/A	99	N/A
12/31/2015	608	74	N/A	103	N/A
9/30/2015	616	83	N/A	114	N/A
6/30/2015	624	91	N/A	125	N/A
3/31/2015	617	90	N/A	111	N/A
12/31/2014	610	89	N/A	96	N/A
9/30/2014	607	83	N/A	91	N/A
6/30/2014	604	76	N/A	86	N/A
3/31/2014	611	79	N/A	96	N/A
12/31/2013	618	82	N/A	107	N/A

アナリストによる今後の成長予測

収入対貯蓄率: BOIR.F's forecast earnings growth (26.2% per year) is above the savings rate (2.5%).

収益対市場: BOIR.F's earnings (26.2% per year) are forecast to grow faster than the US market (15.9% per year).

高成長収益: BOIR.F's earnings are expected to grow significantly over the next 3 years.

収益対市場: BOIR.F's revenue (3.6% per year) is forecast to grow slower than the US market (8.8% per year).

高い収益成長: BOIR.F's revenue (3.6% per year) is forecast to grow slower than 20% per year.

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: BOIR.F's Return on Equity is forecast to be low in 3 years time (13.1%).

Boiron 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Recent updates

Boiron SA (ENXTPA:BOI) signed an agreement to acquire 70% stake in Abbi.

Boiron SA to Report Fiscal Year 2020 Results on Mar 10, 2021

French Agency for the Safety of Medicines and Health Products Selects Emmac Life Sciences Group in Partnership with Boiron as the Suppliers for the Forthcoming French Medical Cannabis Trial

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘